DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 74 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Banswara Syntex Limited — Action(s) taken or orders passed

NSE 4d ago·26 Aug 2026, 11:18 am

Banswara Syntex

Banswara Syntex Limited has informed stock exchanges regarding the receipt of certain regulatory orders or actions. The company has not yet disclosed the specific nature or details of these orders in its public announcement.

For investors, this development is significant as it signals that the company is navigating a regulatory process. The exact implications of the orders will depend on their content, which remains to be seen. Until the company provides clarity, the stock's performance may remain volatile.

Investors should monitor the company's subsequent filings for more information. Keeping an eye on the broader context of the order and its potential impact on the company's operations will be crucial for understanding the situation.